Outcomes Following Extended Surgery for Retroperitoneal Sarcomas: Results From a UK Referral Centre

Annals of Surgical Oncology

Volumn 22, Issue 11, 2015, Pages 3550-3556

  Pasquali, Sandro ^a   Vohra, Ravinder ^a,b   Tsimopoulou, Ioanna ^b   Vijayan, Deepak ^a   Gourevitch, David ^a   Desai, Anant ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL SURGERY; ADULT; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLON RESECTION; CYSTECTOMY; DISEASE FREE SURVIVAL; DISTAL PANCREATECTOMY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HYSTERECTOMY; LENGTH OF STAY; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; NEPHRECTOMY; OUTCOME ASSESSMENT; PANCREAS RESECTION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PRIMARY EXTENDED RESECTION; PRIMARY TUMOR; REOPERATION; RETROPERITONEAL SARCOMA; SALPINGOOOPHORECTOMY; SMALL INTESTINE RESECTION; SURGICAL INFECTION; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; UNITED KINGDOM; ADRENALECTOMY; ADVERSE EFFECTS; AGED; CANCER CENTER; GREAT BRITAIN; MINIMAL RESIDUAL DISEASE; OVARIECTOMY; PATHOLOGY; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDY; SALPINGECTOMY; SARCOMA; SMALL INTESTINE; SPLENECTOMY; TREATMENT OUTCOME; TUMOR INVASION; URETER;

ADRENALECTOMY; AGED; CANCER CARE FACILITIES; COLECTOMY; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; GREAT BRITAIN; HUMANS; HYSTERECTOMY; INTESTINE, SMALL; LENGTH OF STAY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM, RESIDUAL; NEPHRECTOMY; OVARIECTOMY; PANCREATECTOMY; REOPERATION; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; SALPINGECTOMY; SARCOMA; SPLENECTOMY; SURGICAL PROCEDURES, OPERATIVE; SURVIVAL RATE; TREATMENT OUTCOME; URETER;

EID: 84941416078     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4380-z     Document Type: Article

References (45)

1. Cormier JN, Pollock RE. Soft tissue sarcomas. CA Cancer J Clin. 2004;54:94–109.
2. Mastrangelo G, Coindre JM, Ducimetiere F, et al. Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions. Cancer. 2012;118:5339–48.
3. Miah AB, Hannay J, Benson C, et al. Optimal management of primary retroperitoneal sarcoma: an update. Expert Rev Anticancer Ther. 2014;14:565-579.
4. ESMO / European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23 (Suppl 7):vii92–9.
5. Grimer R, Judson I, Peake D, Seddon B. Guidelines for the management of soft tissue sarcomas. Sarcoma. 2010;2010:506182.
6. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Soft tissue sarcoma. Fort Washington: National Comprehensive Cancer Network; 2014.
7. Anaya DA, Lev DC, Pollock RE. The role of surgical margin status in retroperitoneal sarcoma. J Surg Oncol. 2008;98:607–10.
8. Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228:355–65.
9. Bonvalot S, Miceli R, Berselli M, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol. 2010;17:1507–14.
10. Gronchi A, Bonvalot S, Le Cesne A, Casali PG. Resection of uninvolved adjacent organs can be part of surgery for retroperitoneal soft tissue sarcoma. J Clin Oncol. 2009;27:2106–7; author reply 2107-2108.
11. Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009;27:24–30.
12. Gronchi A, Miceli R, Colombo C, et al. Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas. Ann Oncol. 2012;23:1067–73.
13. Bonvalot S, Raut CP, Pollock RE, et al. Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol. 2012;19:2981–91.
14. Strauss DC, Sandhu B, Hayes A, Thomas M. Surgical management of retroperitoneal leiomyosarcoma: tumour grade and site influence outcome. Connective Tissue Oncology Society 17th Annual Meeting; 14–17 Nov 2012; Prague.
15. Fiore M, Colombo C, Locati P, et al. Surgical technique, morbidity, and outcome of primary retroperitoneal sarcoma involving inferior vena cava. Ann Surg Oncol. 2012;19:511–8.
16. Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27:31–7.
17. Pollock RE. Extended surgery for retroperitoneal sarcoma: too much surgery for some and not enough for others? Oncology (Williston Park). 2013;27:641–2.
18. Pisters PW. Resection of some—but not all—clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas. J Clin Oncol. 2009;27:6–8.
19. Soft tissue and visceral sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25 (Suppl 3):iii102–12.
20. Trans-Atlantic RPS Working Group. Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol. 2015;22(1):256–63.
21. Wilkinson MJ, Martin JL, Khan AA, Hayes AJ, Thomas JM, Strauss DC. Percutaneous core needle biopsy in retroperitoneal sarcomas does not influence local recurrence or overall survival. Ann Surg Oncol. 2014. doi:10.1245/s10434-014-4059-x.
22. Trojani M, Contesso G, Coindre JM, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984;33:37-42.
23. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.
24. Mussi C, Colombo P, Bertuzzi A, et al. Retroperitoneal sarcoma: is it time to change the surgical policy? Ann Surg Oncol. 2011;18:2136–42.
25. Gronchi A, Pollock R. Surgery in retroperitoneal soft tissue sarcoma: a call for a consensus between Europe and North America. Ann Surg Oncol. 2011;18:2107–10.
26. Gronchi A, Miceli R, Allard MA, et al. Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection. Ann Surg Oncol. 2014. doi:10.1245/s10434-014-4130-7.
27. Bremjit PJ, Jones RL, Chai X, et al. A contemporary large single-institution evaluation of resected retroperitoneal sarcoma. Ann Surg Oncol. 2014;21:2150–8.
28. Tseng WW, Madewell JE, Wei W, et al. Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection? Ann Surg Oncol. 2014;21:2136–43.
29. Ferrario T, Karakousis CP. Retroperitoneal sarcomas: grade and survival. Arch Surg. 2003;138:248–51.
30. Kilkenny JW 3rd, Bland KI, Copeland EM 3rd. Retroperitoneal sarcoma: the University of Florida experience. J Am Coll Surg. 1996;182:329–39.
31. Stoeckle E, Coindre JM, Bonvalot S, et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001;92:359–68.
32. Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg. 2003;238:358–70; discussion 370-351.
33. Hassan I, Park SZ, Donohue JH, et al. Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience. Ann Surg. 2004;239:244–50.
34. Gronchi A, Casali PG, Fiore M, et al. Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. Cancer. 2004;100:2448–55.
35. van Dalen T, Plooij JM, van Coevorden F, et al. Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol. 2007;33:234–8.
36. Lehnert T, Cardona S, Hinz U, et al. Primary and locally recurrent retroperitoneal soft-tissue sarcoma: local control and survival. Eur J Surg Oncol. 2009;35:986–93.
37. Strauss DC, Hayes AJ, Thway K, Moskovic EC, Fisher C, Thomas JM. Surgical management of primary retroperitoneal sarcoma. Br J Surg. 2010;97:698–706.
38. Cho SY, Moon KC, Cheong MS, Kwak C, Kim HH, Ku JH. Significance of microscopic margin status in completely resected retroperitoneal sarcoma. J Urol. 2011;186:59–65.
39. Gronchi A, Miceli R, Shurell E, et al. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol. 2013;31:1649–55.
40. Anaya DA, Lahat G, Wang X, et al. Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. Ann Oncol. 2010;21:397–402.
41. Rossi CR, Vecchiato A, Mastrangelo G, et al. Adherence to treatment guidelines for primary sarcomas affects patient survival: a side study of the European CONnective TIssue CAncer NETwork (CONTICANET). Ann Oncol. 2013;24:1685–91.
42. Ray-Coquard I, Thiesse P, Ranchere-Vince D, et al. Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas. Ann Oncol. 2004;15:307–15.
43. Toulmonde M, Bonvalot S, Meeus P, et al. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Ann Oncol. 2014;25:735–42.
44. Toulmonde M, Bonvalot S, Ray-Coquard I, et al. Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Ann Oncol. 2014;25:730–4.
45. Benson C, Judson I. Role of expert centres in the management of sarcomas: a UK perspective. Eur J Cancer. 2014;50:1951–6.